Page last updated: 2024-11-08

biguanides and Psoriasis

biguanides has been researched along with Psoriasis in 3 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research Excerpts

ExcerptRelevanceReference
"Psoriasis is a common chronic inflammatory skin disease that manifests as scaly erythematous plaques as a consequence of keratinocyte hyperproliferation and inflammation."2.55Glycemic Control in the Treatment of Psoriasis. ( Ip, W; Kirchhof, MG, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ip, W1
Kirchhof, MG1
Klode, J1
Körber, A1
Dissemond, J1
Laloux, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism: A Double-Blind, Randomized, Placebo-Controlled Study[NCT03629639]Phase 480 participants (Anticipated)Interventional2018-09-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for biguanides and Psoriasis

ArticleYear
Glycemic Control in the Treatment of Psoriasis.
    Dermatology (Basel, Switzerland), 2017, Volume: 233, Issue:1

    Topics: Biguanides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans;

2017

Other Studies

2 other studies available for biguanides and Psoriasis

ArticleYear
[Psoriasis vulgaris as a trigger for a superficial multilocular pyoderma gangrenosum?].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2009, Volume: 60, Issue:7

    Topics: Biguanides; Dermatologic Agents; Diagnosis, Differential; Humans; Male; Middle Aged; Psoriasis; Pyod

2009
[Dermatologic study of a new ointment: Dexatopic].
    Bruxelles medical, 1971, Volume: 51, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Biguanides; Child; Child, Preschool; Dermatitis;

1971